Glide Healthcare

Portfolio · 1

Nyxoah

Hypoglossal Nerve Stimulation Therapy for Obstructive Sleep Apnea

1 round $20.0M committed Latest: 2016-07

Investment activity

1 portfolio exit on record.

Q&A

What is Glide Healthcare's primary investment focus?

Glide Healthcare primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.

Can you name a notable exit for Glide Healthcare?

A notable exit for Glide Healthcare is Nyxoah, which went public on Euronext in September 2020 with a valuation of $423M.

What is the most recent exit for Glide Healthcare?

Glide Healthcare's most recent exit was Nyxoah, which completed a Public Offering (POEvent) in September 2020.

Which portfolio company has Glide Healthcare invested in that has gone public?

Glide Healthcare has invested in Nyxoah, which is currently a public company.

What was the funding stage of Glide Healthcare's investment in Nyxoah?

Glide Healthcare participated in a B Round for Nyxoah in July 2016.

What is Glide Healthcare's geographic focus?

Glide Healthcare is headquartered in the Netherlands.